SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Diagnostic: CBS/PSP Differential Diagnosis

diagnostic 2,089 words KG: Biomarker 2026-03-29

section:diagnostics kind:diagnostic topic:cbs topic:psp topic:parkinsons topic:alzheimers

Contents

CBS/PSP Differential Diagnosis

Knowledge Graph

Related Hypotheses (24)

ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro
Score: 0.66 Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57 Purinergic Signaling Polarization Control
Score: 0.55 Heterogeneous astrocyte activation states differentially imp
Score: 0.52 GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.52

Membrane Cholesterol Gradient Modulators
Score: 0.52 SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK
Score: 0.51 Aquaporin-4 Polarization Rescue
Score: 0.51 Circadian Rhythm Entrainment of Reactive Astrocytes
Score: 0.48 Astrocyte-Mediated Neuronal Epigenetic Rescue
Score: 0.48 Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46 Astrocyte-Mediated Microglial Memory Erasure
Score: 0.46 Sphingolipid Metabolism Reprogramming
Score: 0.44 Complement C1q Subtype Switching
Score: 0.44 CX43 hemichannel engineering enables size-selective mitochon
Score: 0.41 Glial Glycocalyx Remodeling Therapy
Score: 0.41 Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.41 Ephrin-B2/EphB4 Axis Manipulation
Score: 0.40 SIRT6-NAD+ Axis Enhancement Therapy
Score: 0.39 KDM6A-Mediated H3K27me3 Rejuvenation
Score: 0.38 Extracellular Vesicle Biogenesis Modulation
Score: 0.34 Glymphatic-Mediated Tau Clearance Dysfunction
Score: 0.55 Dual-Circuit Tau Vulnerability Cascade
Score: 0.50 Dopaminergic Ventral Tegmental-Hippocampal Circuit Protectio
Score: 0.49

Related Analyses (15)

4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived Do tau strains or regional cellular environments primarily d
neurodegeneration · failed 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · completed Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived

Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Epigenetic reprogramming in aging neurons
neurodegeneration · archived Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed

Related Experiments (17)

CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.40 N-of-1 Clinical Trial Design for CBS/PSP
clinical · proposed · Score: 0.40 4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40 ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.40 Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40

Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40 CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.40 ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Levodopa Response Determinants in PSP — Biomarker-Guided Pre
clinical · proposed · Score: 0.40 PSP and CBS Biomarker Validation Study
clinical · proposed · Score: 0.40 Tau Pathology Initiation Zone Identification
clinical · proposed · Score: 0.40 Tau Spreading Network Mapping via Spatial Transcriptomics in
clinical · proposed · Score: 0.40 iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · proposed · Score: 0.90 Blood Biomarker vs Tau PET for Treatment Monitoring
clinical · proposed · Score: 0.40 Tau depletion effects on neuronal development in primary cul
exploratory · proposed · Score: 0.90 Microtubule domain analysis in adult axons
exploratory · proposed · Score: 0.80 Pre-Symptomatic Tau Detection in MAPT Mutation Carriers
clinical · proposed · Score: 0.40

Knowledge Graph (11 edges)

Biomarker biomarker_for Thyroid Cancer

Biomarker correlates_with Disease Trajectory

Biomarker biomarker_for Septic Shock

Biomarker involved_in Sepsis Diagnosis

Biomarker biomarker_for Prostate Cancer

Biomarker biomarker_for Aging

Biomarker biomarker_for Amyotrophic Lateral Sclerosis

Biomarker biomarker_for Frontotemporal Dementia

Biomarker biomarker_for Alzheimer's Disease

HMGB1 biomarker_for Biomarker

SciDEX — scidex.ai — Dashboard | Atlas